ATE83375T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE83375T1
ATE83375T1 AT88312287T AT88312287T ATE83375T1 AT E83375 T1 ATE83375 T1 AT E83375T1 AT 88312287 T AT88312287 T AT 88312287T AT 88312287 T AT88312287 T AT 88312287T AT E83375 T1 ATE83375 T1 AT E83375T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
antihypertensive agent
hypertension
beta
therapy
Prior art date
Application number
AT88312287T
Other languages
English (en)
Inventor
John Morris Evans
Robin Edwin Buckingham
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10629550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE83375(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE83375T1 publication Critical patent/ATE83375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88312287T 1988-01-06 1988-12-23 Pharmazeutische zusammensetzungen. ATE83375T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888800199A GB8800199D0 (en) 1988-01-06 1988-01-06 Pharmaceutical preparation
EP88312287A EP0323745B1 (de) 1988-01-06 1988-12-23 Pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE83375T1 true ATE83375T1 (de) 1993-01-15

Family

ID=10629550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88312287T ATE83375T1 (de) 1988-01-06 1988-12-23 Pharmazeutische zusammensetzungen.

Country Status (15)

Country Link
US (1) US5032591A (de)
EP (1) EP0323745B1 (de)
JP (1) JPH01224316A (de)
KR (1) KR890011591A (de)
AT (1) ATE83375T1 (de)
AU (1) AU614008B2 (de)
CA (1) CA1317228C (de)
DE (1) DE3876773T2 (de)
DK (1) DK2689A (de)
ES (1) ES2042776T3 (de)
GB (1) GB8800199D0 (de)
GR (1) GR3006857T3 (de)
NZ (1) NZ227518A (de)
PT (1) PT89388B (de)
ZA (1) ZA8944B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921972T2 (de) * 1988-12-13 1995-11-16 Beecham Group Plc Benzopyran und verwandte Verbindungen.
FR2645021A1 (fr) * 1989-03-30 1990-10-05 Sanofi Sa Utilisation d'un agoniste potassique dans le traitement du glaucome
FR2653662B1 (fr) * 1989-10-31 1994-05-13 Rhone Poulenc Sante Application du n-methyl (pyridyl-3)-2 tetrahydrothiopyranne-carbothioamide-2-oxyde-1 a la preparation de medicaments destines au traitement de l'insuffisance coronarienne.
FR2657872B2 (fr) * 1989-11-06 1992-06-12 Sanofi Sa Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
TW224941B (de) * 1989-11-08 1994-06-11 Yamanouchi Pharma Co Ltd
DE4004268A1 (de) * 1990-02-13 1991-08-14 Merck Patent Gmbh Pharmazeutische zubereitung
WO1992004054A1 (en) * 1990-08-30 1992-03-19 STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon Substituted amidines having high binding to the sigma receptor and the use thereof
US5643921A (en) * 1990-09-26 1997-07-01 E.R. Squibb & Sons, Inc. Cardiopulmonary bypass and organ transplant using a potassium channel activator
GB9124754D0 (en) * 1991-11-21 1992-01-15 Smithkline Beecham Plc Pharmaceuticals
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
EP1836183A2 (de) * 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiroderivate als lipoxigenaseinhibitoren
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
MX2009002002A (es) * 2006-08-23 2009-07-22 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potasio.
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
MX2009005652A (es) * 2006-11-28 2009-08-07 Valeant Pharmaceuticals Int Analogos 1,4 diamino biciclicos de retigabina como moduladores de canales de potasio.
US20080207073A1 (en) * 2007-02-22 2008-08-28 David Michael Jones Coated multi-purpose fabric
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
EP0076075B1 (de) * 1981-09-25 1986-11-20 Beecham Group Plc Benzopyran-Verbindungen mit pharmazeutischer Wirkung
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
EP0093535B1 (de) * 1982-04-28 1986-12-30 Beecham Group Plc Chromenen und Chromanen
EP0095316B1 (de) * 1982-05-21 1986-12-03 Beecham Group Plc Pharmazeutisch wirksame Aminobenzopyrane
EP0107423B1 (de) * 1982-10-19 1986-07-23 Beecham Group Plc Chromanen und Chromenen
GB8308063D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
EP0126367B1 (de) * 1983-05-18 1994-10-12 Beecham Group Plc Chroman- und Chromenderivate
GB8313679D0 (en) * 1983-05-18 1983-06-22 Beecham Group Plc Active compounds
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
EP0139992B1 (de) * 1983-09-01 1988-12-28 Beecham Group Plc Chromanol-Derivate
DE3477779D1 (en) * 1983-10-13 1989-05-24 Beecham Group Plc Chroman derivatives
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8513369D0 (en) * 1985-05-28 1985-07-03 Beecham Group Plc Treatment
DE3682331D1 (de) * 1985-06-08 1991-12-12 Beecham Group Plc Pyrano(3,2-c)pyridinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
GB8521857D0 (en) * 1985-09-03 1985-10-09 Beecham Group Plc Active compounds
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
GB8613786D0 (en) * 1986-06-06 1986-07-09 Beecham Group Plc Active compounds
GB8625185D0 (en) * 1986-10-21 1986-11-26 Beecham Group Plc Active compounds
DE3776111D1 (de) * 1986-12-06 1992-02-27 Beecham Group Plc Pharmazeutische zubereitungen.
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
EP0277611B1 (de) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen

Also Published As

Publication number Publication date
JPH01224316A (ja) 1989-09-07
NZ227518A (en) 1991-08-27
GB8800199D0 (en) 1988-02-10
DE3876773D1 (de) 1993-01-28
CA1317228C (en) 1993-05-04
EP0323745A3 (en) 1990-03-21
ZA8944B (en) 1990-09-26
EP0323745B1 (de) 1992-12-16
AU2769689A (en) 1989-07-06
DK2689A (da) 1989-07-07
GR3006857T3 (de) 1993-06-30
PT89388A (pt) 1990-02-08
DK2689D0 (da) 1989-01-04
US5032591A (en) 1991-07-16
ES2042776T3 (es) 1993-12-16
AU614008B2 (en) 1991-08-15
KR890011591A (ko) 1989-08-21
DE3876773T2 (de) 1993-04-29
EP0323745A2 (de) 1989-07-12
PT89388B (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
DE3876773T2 (de) Pharmazeutische zusammensetzungen.
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
SE8804629D0 (sv) New therapeutically active compounds
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
IL92672A0 (en) Retroviral protease inhibitors,their preparation and pharmaceutical compositions containing them
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ATE71535T1 (de) Pharmazeutische zubereitungen.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
PL339073A1 (en) Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents
DE69128254D1 (de) Antihypertensive benzopyran-derivate
IL92217A0 (en) Optically active benzoxazines and benzothiazines,their stereospecific preparation and pharmaceutical compositions containing them
IL92107A0 (en) Quinazoline derivatives,and pharmaceutical compositions containing them
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
ATE102031T1 (de) Pharmazeutische zubereitung.
FI874823A0 (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
BR1100888A (pt) Variantes de ativador de plasminogênios de tecido, composições e métodos de uso da mesma
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.